You are here: Home > Investor Relations

 Investor Relations

 
 Recent Releases

 Archived Releases

 Anual Meeting

 Analyst Coverage

 Corporate Governance

 SEC Filings

 Transfer Agent

 Auditors

 Investor Package

 E-Mail Alerts
 
 Contact Us

12/2/2009 ELITE PHRAMACEUTALS AND THEPHARMANETWORK ANNOUNCE FDA APPROVAL FOR GENERIC METHADONE TABLETS

11/16/2009 Elite Pharmaceuticals, Inc. To Host Quarterly Conference Call on Wednesday, November 18, 2009

11/5/2009 ELITE PHARMACEUTICALS, INC. ANNOUNCES SECOND CLOSING OF STRATEGIC ALLIANCE AGREEMENT WITH EPIC PHARMA

9/21/2009 ELITE PHARMACEUTICALS APPOINTS CHIEF EXECUTIVE OFFICER AND CHIEF SCIENTIFIC OFFICER

8/24/2009 Elite Pharmaceuticals, Inc. Hosts Quarterly Conference Call

More Releases...

Click Here for a complete archive


Elite Pharmaceuticals, Inc. 165 Ludlow Ave., Northvale, NJ 07647    Phone:  201-750-2646  Fax:  201-750-2755 
E Mail:  webmaster@elitepharma.com